Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(20S)-21-hydroxy-20-methylpregn-4-en-3-one + NADPH + H+
? + NADP+
-
-
-
?
1,4-androstadien-17beta-ol-3-one + NADPH + H+
?
-
-
-
-
?
11-deoxycortisol + NADPH
?
-
-
-
-
?
11beta,17alpha,21-trihydroxy-pregn-4-en-3,20-dione + NADPH
11beta,17alpha,21-trihydroxypregnan-3,20-dione + NADP+
17alpha,21-dihydroxy-pregn-4-en-3,20-dione + NADPH
17alpha,21-dihydroxy-pregnan-3,20-dione + NADP+
17alpha-hydroxyprogesterone + NADPH
?
-
-
-
-
?
17alpha-methylestr-4-en-3-one + NADPH
17alpha-methylestran-3-one + NADP+
17beta-hydroxyandrost-4-en-3-one + NADPH
17beta-hydroxy-5beta-androstan-3-one + NADP+
17beta-hydroxyestr-4-en-3-one + NADPH
17-hydroxyestran-3-one + NADP+
2-cyclohexen-1-one + NADPH + H+
? + NADP+
-
-
-
?
2-cyclohexen-1-one + NADPH + H+
cyclohexanone + NADP+
4-androstene-3,17-dione + NADPH
5beta-androstan-3,17-dione + NADP+
4-androstene-3,17-dione + NADPH + H+
5beta-androstan-3,15-dione + 3alpha-hydroxy-5beta-androstan-17-one + NADP+
-
-
-
?
4-androstene-3,17-dione + NADPH + H+
5beta-androstan-3,17-dione + NADP+
-
-
-
?
4-androstene-3,17-dione + NADPH + H+
?
-
-
-
-
?
4-cholesten-7alpha-ol-3-one + NADPH + H+
?
-
-
-
-
?
4-estren-17beta-ol-3-one + NADPH + H+
?
-
-
-
-
?
7alpha,12alpha-dihydroxy-4-cholesten-3-one + NADPH
7alpha,12alpha-dihydroxy-5-beta-cholestan-3-one + NADP+
-
-
-
-
?
7alpha,12alpha-dihydroxy-4-cholesten-3-one + NADPH + H+
?
-
-
-
?
7alpha,12beta-dihydroxy-4-cholesten-3-one + NADPH + H+
(5beta,7alpha,12beta)-7,12-dihydroxycholestan-3-one + NADP+
-
-
-
?
7alpha-hydroxy-4-cholesten + NADPH
7alpha-hydroxy-5beta-cholestan-3-one + NADP+
-
-
-
?
7alpha-hydroxy-4-cholesten-3-one + NADPH
(5beta,7alpha)-7-hydroxycholestan-3-one + NADP+
-
-
-
?
7alpha-hydroxy-4-cholesten-3-one + NADPH + H+
7alpha-hydroxy-5beta-cholestan-3-one + NADP+
-
-
-
-
r
7alpha-hydroxy-4-cholesten-3-one + NADPH + H+
?
-
-
-
?
aldosterone + NADPH + H+
?
-
-
-
-
?
androst-4-en-3,17-dione + NADPH
5beta-androstan-3,17-dione + NADP+
androstenedione + NADPH + H+
?
-
-
-
?
cholest-4-en-3-one + NADPH + H+
5beta-cholestan-3-one + NADP+
-
-
-
?
cholestenone + NADPH + H+
?
-
-
-
-
?
cortexone + NADPH
21-trihydroxy-5beta-pregnane-3,20-dione + NADP+
corticosterone + NADPH + H+
?
cortisol + NADPH
11beta,17,21-trihydroxy-5beta-pregnane-3,20-dione + NADP+
cortisol + NADPH + H+
11beta,17,21-trihydroxy-5beta-pregnane-3,20-dione + NADP+
-
-
-
?
cortisol + NADPH + H+
?
-
-
-
-
?
cortisone + NADPH + H+
17,21-dihydroxy-5beta-pregnane-3,11,20-trione + NADP+
cortisone + NADPH + H+
5beta-17,21dihydroxy-pregnan-3,11,20-trione + NADP+
cortisone + NADPH + H+
?
-
-
-
-
?
DELTA 4-cholestene-7alpha,12alpha-diol-3-one + NADPH + H+
5beta-cholestane-7alpha,12alpha-diol-3-one + NADP+
-
a bile acid intermediate
-
-
?
DELTA4-cholesten-7alpha-ol-3-one + NADPH + H+
5beta-cholestan-7alpha-ol-3-one + NADP+
-
a bile acid intermediate
-
-
?
deoxycorticosterone + NADPH
pregnan-21-ol-3,20-dione + NADP+
dexamethasone + NADPH + H+
? + NADP+
substrate of splice variant AKR1D1-002
-
-
?
epitestosterone + NADPH + H+
?
-
-
-
-
?
ethyl acrylate + NADPH + H+
? + NADP+
-
-
-
?
prednisolone + NADPH + H+
? + NADP+
substrate of splice variant AKR1D1-002
-
-
?
progesterone + NADPH + H+
5beta-pregnane-3,20-dione + NADP+
progesterone + NADPH + H+
?
progesterone + NADPH + H+
pregnan-3,20-dione + NADP+
testosterone + NADPH + H+
(5beta,17beta)-17-hydroxyandrostan-3-one + NADP+
testosterone + NADPH + H+
?
additional information
?
-
11beta,17alpha,21-trihydroxy-pregn-4-en-3,20-dione + NADPH

11beta,17alpha,21-trihydroxypregnan-3,20-dione + NADP+
-
-
-
?
11beta,17alpha,21-trihydroxy-pregn-4-en-3,20-dione + NADPH
11beta,17alpha,21-trihydroxypregnan-3,20-dione + NADP+
-
-
-
?
17alpha,21-dihydroxy-pregn-4-en-3,20-dione + NADPH

17alpha,21-dihydroxy-pregnan-3,20-dione + NADP+
-
-
-
?
17alpha,21-dihydroxy-pregn-4-en-3,20-dione + NADPH
17alpha,21-dihydroxy-pregnan-3,20-dione + NADP+
-
-
-
?
17alpha-methylestr-4-en-3-one + NADPH

17alpha-methylestran-3-one + NADP+
-
-
-
?
17alpha-methylestr-4-en-3-one + NADPH
17alpha-methylestran-3-one + NADP+
-
-
-
?
17beta-hydroxyandrost-4-en-3-one + NADPH

17beta-hydroxy-5beta-androstan-3-one + NADP+
-
trivial name testosterone
-
?
17beta-hydroxyandrost-4-en-3-one + NADPH
17beta-hydroxy-5beta-androstan-3-one + NADP+
-
trivial name testosterone
-
?
17beta-hydroxyandrost-4-en-3-one + NADPH
17beta-hydroxy-5beta-androstan-3-one + NADP+
-
trivial name testosterone
-
?
17beta-hydroxyestr-4-en-3-one + NADPH

17-hydroxyestran-3-one + NADP+
-
-
-
?
17beta-hydroxyestr-4-en-3-one + NADPH
17-hydroxyestran-3-one + NADP+
-
-
-
?
2-cyclohexen-1-one + NADPH + H+

cyclohexanone + NADP+
-
-
-
?
2-cyclohexen-1-one + NADPH + H+
cyclohexanone + NADP+
-
-
-
-
?
4-androstene-3,17-dione + NADPH

5beta-androstan-3,17-dione + NADP+
-
-
-
?
4-androstene-3,17-dione + NADPH
5beta-androstan-3,17-dione + NADP+
-
-
-
?
4-androstene-3,17-dione + NADPH
5beta-androstan-3,17-dione + NADP+
-
-
-
-
?
4-androstene-3,17-dione + NADPH
5beta-androstan-3,17-dione + NADP+
-
-
-
-
?
4-androstene-3,17-dione + NADPH
5beta-androstan-3,17-dione + NADP+
-
-
-
-
?
aldosterone + NADPH

?
-
low activity
-
-
?
aldosterone + NADPH
?
-
-
-
-
?
androst-4-en-3,17-dione + NADPH

5beta-androstan-3,17-dione + NADP+
-
-
-
?
androst-4-en-3,17-dione + NADPH
5beta-androstan-3,17-dione + NADP+
-
-
-
?
androst-4-en-3,17-dione + NADPH
5beta-androstan-3,17-dione + NADP+
-
-
-
?
cortexone + NADPH

21-trihydroxy-5beta-pregnane-3,20-dione + NADP+
-
-
-
?
cortexone + NADPH
21-trihydroxy-5beta-pregnane-3,20-dione + NADP+
-
-
-
?
corticosterone + NADPH + H+

?
-
-
-
-
?
corticosterone + NADPH + H+
?
-
low activity
-
-
?
cortisol + NADPH

11beta,17,21-trihydroxy-5beta-pregnane-3,20-dione + NADP+
-
-
-
?
cortisol + NADPH
11beta,17,21-trihydroxy-5beta-pregnane-3,20-dione + NADP+
-
-
-
?
cortisol + NADPH

?
-
very low activity
-
-
?
cortisol + NADPH
?
-
-
-
-
?
cortisone + NADPH

?
-
-
-
-
?
cortisone + NADPH
?
-
-
-
-
?
cortisone + NADPH + H+

17,21-dihydroxy-5beta-pregnane-3,11,20-trione + NADP+
-
-
-
?
cortisone + NADPH + H+
17,21-dihydroxy-5beta-pregnane-3,11,20-trione + NADP+
-
-
-
-
?
cortisone + NADPH + H+

5beta-17,21dihydroxy-pregnan-3,11,20-trione + NADP+
-
-
-
?
cortisone + NADPH + H+
5beta-17,21dihydroxy-pregnan-3,11,20-trione + NADP+
-
-
-
?
cortisone + NADPH + H+
5beta-17,21dihydroxy-pregnan-3,11,20-trione + NADP+
-
-
-
?
cortisone + NADPH + H+
5beta-17,21dihydroxy-pregnan-3,11,20-trione + NADP+
-
-
-
?
cortisone + NADPH + H+
5beta-17,21dihydroxy-pregnan-3,11,20-trione + NADP+
-
-
-
-
?
cortisone + NADPH + H+
5beta-17,21dihydroxy-pregnan-3,11,20-trione + NADP+
-
-
-
?
cortisone + NADPH + H+
5beta-17,21dihydroxy-pregnan-3,11,20-trione + NADP+
-
-
-
?
cortisone + NADPH + H+
5beta-17,21dihydroxy-pregnan-3,11,20-trione + NADP+
-
-
-
?
cortisone + NADPH + H+
5beta-17,21dihydroxy-pregnan-3,11,20-trione + NADP+
-
high substrate specificity
-
ir
cortisone + NADPH + H+
5beta-17,21dihydroxy-pregnan-3,11,20-trione + NADP+
-
-
-
?
deoxycorticosterone + NADPH

pregnan-21-ol-3,20-dione + NADP+
-
-
-
?
deoxycorticosterone + NADPH
pregnan-21-ol-3,20-dione + NADP+
-
-
-
?
progesterone + NADPH

?
-
-
-
-
?
progesterone + NADPH
?
-
-
-
-
?
progesterone + NADPH + H+

5beta-pregnane-3,20-dione + NADP+
-
-
-
?
progesterone + NADPH + H+
5beta-pregnane-3,20-dione + NADP+
-
no substrate inhibition observed
-
-
?
progesterone + NADPH + H+
5beta-pregnane-3,20-dione + NADP+
-
-
-
?
progesterone + NADPH + H+
5beta-pregnane-3,20-dione + NADP+
-
-
-
ir
progesterone + NADPH + H+
5beta-pregnane-3,20-dione + NADP+
-
-
-
-
?
progesterone + NADPH + H+
5beta-pregnane-3,20-dione + NADP+
-
-
-
?
progesterone + NADPH + H+
5beta-pregnane-3,20-dione + NADP+
5alpha-pregnane-3,20-dione, the 5alpha-isomer of the pregnane-3,20-dione is not formed
-
-
ir
progesterone + NADPH + H+
5beta-pregnane-3,20-dione + NADP+
-
stereospecific reduction of the 4-double-bond in cardenolide biosynthesis
-
-
?
progesterone + NADPH + H+
5beta-pregnane-3,20-dione + NADP+
-
highest substrate specificity
-
-
ir
progesterone + NADPH + H+
5beta-pregnane-3,20-dione + NADP+
-
-
-
-
?
progesterone + NADPH + H+
5beta-pregnane-3,20-dione + NADP+
-
-
-
?
progesterone + NADPH + H+

?
-
-
-
?
progesterone + NADPH + H+
?
-
-
-
-
?
progesterone + NADPH + H+

pregnan-3,20-dione + NADP+
-
-
-
?
progesterone + NADPH + H+
pregnan-3,20-dione + NADP+
-
-
-
?
progesterone + NADPH + H+
pregnan-3,20-dione + NADP+
-
-
-
?
testosterone + NADPH + H+

(5beta,17beta)-17-hydroxyandrostan-3-one + NADP+
-
-
-
?
testosterone + NADPH + H+
(5beta,17beta)-17-hydroxyandrostan-3-one + NADP+
-
-
-
?
testosterone + NADPH + H+
(5beta,17beta)-17-hydroxyandrostan-3-one + NADP+
-
-
-
-
?
testosterone + NADPH + H+
(5beta,17beta)-17-hydroxyandrostan-3-one + NADP+
-
-
-
?
testosterone + NADPH + H+
(5beta,17beta)-17-hydroxyandrostan-3-one + NADP+
substrate of splice variant AKR1D1-002
-
-
?
testosterone + NADPH + H+
(5beta,17beta)-17-hydroxyandrostan-3-one + NADP+
-
-
-
-
?
testosterone + NADPH + H+
(5beta,17beta)-17-hydroxyandrostan-3-one + NADP+
-
-
-
-
?
testosterone + NADPH + H+

?
-
-
-
-
?
testosterone + NADPH + H+
?
-
-
-
?
additional information

?
-
pregnenolone, 21-OH-pregenenolone and isoprogesterone are not accepted by recombinant 5beta-POR
-
-
?
additional information
?
-
-
pregnenolone, 21-OH-pregenenolone and isoprogesterone are not accepted by recombinant 5beta-POR
-
-
?
additional information
?
-
-
AKR1D1 catalyzes the stereospecific reduction of the delta4-double-bond of circulating steroid hormones that contain the delta4-3-ketosteroid functionality, e.g. the reduction of testosteron, progesterone and cortisol to yield the corresponding 5-dihydrosteroid
-
-
?
additional information
?
-
-
aldo-keto reductases are a major superfamily of monomeric NADPH-dependent carbonyl oxidoreductases, active site contains conserved residues D50, Y55, K84, and H117
-
-
?
additional information
?
-
-
the steroid 5beta-reductases catalyze a reaction that is unique in steroid enzymology since the resultant product contains a cis-A/B ring configuration and accordingly contains a 90° bend, the cis-A/B ring configuration is an essential characteristic of cardiac glycosides, e.g. digioxin and bile acids and their precursors
-
-
?
additional information
?
-
-
the recombinant enzyme catalyzes the stereospecific reduction of the delta4-double bond of several steroids with a 3-oxo,delta4,5 structure
-
-
?
additional information
?
-
AKR1D1 catalyzes reduction of DELTA4-ene double bonds in steroid hormones and bile acid precursors. Determination of reaction mechanism by mutational analysis revealing that the 4-pro-R hydride is transferred from the re-face of the nicotinamide ring to C5 of the steroid substrate. E120, a unique substitution in the AKR catalytic tetrad, permits a deeper penetration of the steroid substrate into the active site to promote optimal reactant positioning. It participates with Y58 to create a superacidic oxyanion hole for polarization of the C3 ketone, no role for K87 in the proton relay, overview
-
-
?
additional information
?
-
-
AKR1D1 catalyzes reduction of DELTA4-ene double bonds in steroid hormones and bile acid precursors. Determination of reaction mechanism by mutational analysis revealing that the 4-pro-R hydride is transferred from the re-face of the nicotinamide ring to C5 of the steroid substrate. E120, a unique substitution in the AKR catalytic tetrad, permits a deeper penetration of the steroid substrate into the active site to promote optimal reactant positioning. It participates with Y58 to create a superacidic oxyanion hole for polarization of the C3 ketone, no role for K87 in the proton relay, overview
-
-
?
additional information
?
-
the large steroid-binding site of this enzyme also contains a subsite in which the androstenedione molecule is bound, steroid-binding cavity structure of h5 beta-red, structure comparison
-
-
?
additional information
?
-
-
the large steroid-binding site of this enzyme also contains a subsite in which the androstenedione molecule is bound, steroid-binding cavity structure of h5 beta-red, structure comparison
-
-
?
additional information
?
-
-
AKR1D1 catalyzes the central 5beta-reduction step and reduces bile acid precursors such as DELTA4-cholesten-7alpha-ol-3-one and DELTA 4-cholestene-7alpha,12alpha-diol-3-one to 5beta-cholestan-7alpha-ol-3-one and 5beta-cholestane-7alpha,12alpha-diol-3-one, respectively
-
-
?
additional information
?
-
-
substrate specificity of homogeneous human recombinant AKR1D1 using C18, C19, C21, and C27 DELTA4-ketosteroids, AKR1D1 proficiently reduces all the steroids tested at physiological pH, overview
-
-
?
additional information
?
-
-
the enzyme catalyzes stereo-specifically reduces the DELTA4 double bond in 3-keto steroids and sterols to yield the 5beta-hydrogenated product
-
-
?
additional information
?
-
the enzyme catalyzes stereo-specifically reduces the DELTA4 double bond in 3-keto steroids and sterols to yield the 5beta-hydrogenated product
-
-
?
additional information
?
-
splice variant AKR1D1-002 efficiently metabolizes glucocorticoids and androgens and decreases receptor activation. Variants AKR1D1-001 and AKR1D1-006 poorly metabolize dexamethasone, but do not metabolize cortisol, prednisolone, testosterone or androstenedione
-
-
-
additional information
?
-
-
splice variant AKR1D1-002 efficiently metabolizes glucocorticoids and androgens and decreases receptor activation. Variants AKR1D1-001 and AKR1D1-006 poorly metabolize dexamethasone, but do not metabolize cortisol, prednisolone, testosterone or androstenedione
-
-
-
additional information
?
-
-
enzyme is involved in the biosynthesis of ecdysteroids, catalyzes the 5beta-reduction of a 3-oxo-DELTA4-diketol to a 3-oxo-5beta-diketol
-
-
?
additional information
?
-
-
NADH: no effect
-
-
?
additional information
?
-
-
enzyme reduces a variety of C19 and C21 steroids, highest activity with aldosterone
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
17alpha-hydroxyprogesterone + NADPH
?
-
-
-
-
?
2-cyclohexen-1-one + NADPH + H+
cyclohexanone + NADP+
4-androstene-3,17-dione + NADPH
5beta-androstan-3,17-dione + NADP+
aldosterone + NADPH
?
-
low activity
-
-
?
cholest-4-en-3-one + NADPH + H+
5beta-cholestan-3-one + NADP+
-
-
-
?
corticosterone + NADPH + H+
?
-
low activity
-
-
?
cortisol + NADPH
?
-
very low activity
-
-
?
cortisone + NADPH + H+
17,21-dihydroxy-5beta-pregnane-3,11,20-trione + NADP+
DELTA 4-cholestene-7alpha,12alpha-diol-3-one + NADPH + H+
5beta-cholestane-7alpha,12alpha-diol-3-one + NADP+
-
a bile acid intermediate
-
-
?
DELTA4-cholesten-7alpha-ol-3-one + NADPH + H+
5beta-cholestan-7alpha-ol-3-one + NADP+
-
a bile acid intermediate
-
-
?
progesterone + NADPH
?
-
-
-
-
?
progesterone + NADPH + H+
5beta-pregnane-3,20-dione + NADP+
progesterone + NADPH + H+
?
-
-
-
?
testosterone + NADPH + H+
(5beta,17beta)-17-hydroxyandrostan-3-one + NADP+
testosterone + NADPH + H+
?
-
-
-
?
additional information
?
-
2-cyclohexen-1-one + NADPH + H+

cyclohexanone + NADP+
-
-
-
?
2-cyclohexen-1-one + NADPH + H+
cyclohexanone + NADP+
-
-
-
-
?
4-androstene-3,17-dione + NADPH

5beta-androstan-3,17-dione + NADP+
-
-
-
-
?
4-androstene-3,17-dione + NADPH
5beta-androstan-3,17-dione + NADP+
-
-
-
-
?
cortisone + NADPH + H+

17,21-dihydroxy-5beta-pregnane-3,11,20-trione + NADP+
-
-
-
?
cortisone + NADPH + H+
17,21-dihydroxy-5beta-pregnane-3,11,20-trione + NADP+
-
-
-
-
?
progesterone + NADPH + H+

5beta-pregnane-3,20-dione + NADP+
-
-
-
?
progesterone + NADPH + H+
5beta-pregnane-3,20-dione + NADP+
-
-
-
-
?
progesterone + NADPH + H+
5beta-pregnane-3,20-dione + NADP+
-
stereospecific reduction of the 4-double-bond in cardenolide biosynthesis
-
-
?
testosterone + NADPH + H+

(5beta,17beta)-17-hydroxyandrostan-3-one + NADP+
-
-
-
-
?
testosterone + NADPH + H+
(5beta,17beta)-17-hydroxyandrostan-3-one + NADP+
-
-
-
?
additional information

?
-
-
AKR1D1 catalyzes the stereospecific reduction of the delta4-double-bond of circulating steroid hormones that contain the delta4-3-ketosteroid functionality, e.g. the reduction of testosteron, progesterone and cortisol to yield the corresponding 5-dihydrosteroid
-
-
?
additional information
?
-
-
aldo-keto reductases are a major superfamily of monomeric NADPH-dependent carbonyl oxidoreductases, active site contains conserved residues D50, Y55, K84, and H117
-
-
?
additional information
?
-
-
the steroid 5beta-reductases catalyze a reaction that is unique in steroid enzymology since the resultant product contains a cis-A/B ring configuration and accordingly contains a 90° bend, the cis-A/B ring configuration is an essential characteristic of cardiac glycosides, e.g. digioxin and bile acids and their precursors
-
-
?
additional information
?
-
-
AKR1D1 catalyzes the central 5beta-reduction step and reduces bile acid precursors such as DELTA4-cholesten-7alpha-ol-3-one and DELTA 4-cholestene-7alpha,12alpha-diol-3-one to 5beta-cholestan-7alpha-ol-3-one and 5beta-cholestane-7alpha,12alpha-diol-3-one, respectively
-
-
?
additional information
?
-
-
enzyme is involved in the biosynthesis of ecdysteroids, catalyzes the 5beta-reduction of a 3-oxo-DELTA4-diketol to a 3-oxo-5beta-diketol
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.